Biocartis Group NV

Biocartis announces launch of Influenza-Respiratory Virus Panel on the Idylla(TM) platform - Seite 3

---

^[1] WHO: The global burden of disease: 2004 update. WHO Press, Geneva, Switzerland.

^[2] "The Threat of Pandemic Influenza: Are We Ready?"; http://www.ncbi.nlm.nih.gov/books/NBK22148/

^[3] The test is compatible with both dry NPS swabs as well as with a viral transport medium.

 

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biocartis Group NV via Globenewswire

HUG#1970286